Showing 5831-5840 of 8205 results for "".
- Steroids Found to be Widely Prescribed by Dermatologists for Psoriasis Managementhttps://practicaldermatology.com/news/20140220-steroids_found_to_be_widely_prescribed_by_dermatologists_for_psoriasis_management/2459337/
- New JAAD Study Offers Tips for Preventing and Detecting Skin Cancer in People of Colorhttps://practicaldermatology.com/news/20140206-new_jaad_study_offers_tips_for_preventing_and_detecting_skin_cancer_in_people_of_color/2459347/
- Ipsen Announces Clinical Results of Dysport Next Generationhttps://practicaldermatology.com/news/20140205-ipsen_announces_clinical_results_of_dysport_next_generation/2459348/
- Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Millionhttps://practicaldermatology.com/news/20140203-valeant_pharmaceuticals_to_acquire_precision_dermatology_for_475_million/2459351/
- FDA Approves Celluma as OTC Light Therapy Device to Treat Acne and Morehttps://practicaldermatology.com/news/20140121-fda_approves_celluma_as_otc_light_therapy_device_to_treat_acne_and_more/2459366/
- Merz Dermatology Announces Enhanced Naftin Co-Payment Savings Programhttps://practicaldermatology.com/news/20140117-merz_dermatology_announces_enhanced_naftin_co-payment_savings_program/2459370/
- NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indicationshttps://practicaldermatology.com/news/20140102-nexeption_llc_forms_new_company_alexar_therapeutics_inc_to_develop_novel_lxr_agonist_portfolio_for_dermatologic_indications/2459383/NeXeption, LLC, a biopharmaceutical management company that brings together product opportunities, management expertise and funding to reach compelling partnership milestones, has secured $21.5 million in Series A financing to form Alexar Therapeutic
- Mela Sciences Reports Positive Feedback on MelaFind during Clinical Advisory Meetinghttps://practicaldermatology.com/news/20131210-mela_sciences_reports_positive_feedback_on_melafind_during_clinical_advisory_meeting/2459396/
- Lithera Announces Appointment of Dr. Lincoln Krochmal as Chief Medical Officerhttps://practicaldermatology.com/news/20131121-lithera_announces_appointment_of_dr_lincoln_krochmal_as_chief_medical_officer/2459407/Lincoln Krochmal, MD was recently appointed as Chief Medical Officer of Lithera, Inc. According to the company, this appointment reflects the company's continued growth as it prepares to enter la
- Consumer Survey Reveals Widespread Problem of Excessive Sweating and Desire for New Topical Botulinum Toxin Treatmenthttps://practicaldermatology.com/news/20131118-consumer_survey_reveals_widespread_problem_of_excessive_sweating_and_desire_for_new_topical_botulinum_toxin_treatment/2459412/Anterios, Inc announced survey results about current consumer sentiment around exces